• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    CVS, Rite Aid, Walgreens Hit Hard By Online Pharmacy Trend

    7/1/24 12:52:53 PM ET
    $CVS
    $MCK
    $TGT
    $WBA
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples
    Other Pharmaceuticals
    Health Care
    Get the next $CVS alert in real time by email

    A U.S. bankruptcy judge has approved Rite Aid Corp’s (OTC:RADCQ) restructuring plan, enabling the pharmacy chain to reduce its debt by $2 billion and transfer control to a group of lenders.

    Rite Aid filed for Chapter 11 bankruptcy in October 2023, following a fiscal year in which it reported $750 million in losses and $24 billion in revenue.

    During the bankruptcy process, Rite Aid closed hundreds of stores, sold its pharmacy benefit company Elixir, and negotiated settlements with lenders, including its drug distribution partner McKesson Corp (NYSE:MCK) and other creditors.

    Also Read: Rite Aid Forges Path To Financial Recovery With Major Settlement: Report.

    Reuters noted the restructuring saved the company from having to cease operations entirely.

    The restructuring plan also allocated $47.5 million to junior creditors, including individuals and local governments that have sued Rite Aid for its alleged role in the U.S. opioid epidemic.

    Before filing for bankruptcy, Rite Aid faced 1,600 opioid lawsuits, including one from the federal government, accusing the company of ignoring red flags when filling prescriptions for addictive opioid pain medications.

    Rite Aid has resolved opioid claims with 16 of the 17 states in which it operates. Judge Kaplan overruled Maryland’s objection, stating that the state could not delay Rite Aid’s bankruptcy to continue its investigation into the company’s opioid sales.

    Rite Aid, which had more than 2,000 stores at the time of its bankruptcy filing, will emerge from bankruptcy with about 1,300 locations. The company plans to exit bankruptcy within a month.

    It’s a trend that Jonathan Palmer, senior health care analyst at Bloomberg Intelligence, projected will continue especially as the dependency on online services continues to grow. 

    Earlier, Walgreens Boots Alliance Inc (NASDAQ: WBA) announced that it would close a “significant” number of underperforming stores across the U.S. due to ongoing challenges with profitability and declining margins.

    In 2021, CVS Health Corp (NYSE:CVS) announced that it was shuttering 900 of its 10,000 retail locations over a three-year period. 

    Palmer told FOX Business that the closures were the culmination of several different events, but online pharmacies contributed to their downfall. 

    “More consumers buy online than ever before and with next-day delivery in many cases — the value proposition of retail pharmacy isn’t as compelling,” Palmer said. 

    He argued that pharmacies are convenient for household products but aren’t cheap. 

    “They’re at a significant premium to a Walmart Inc (NYSE:WMT) or a Target Corp (NYSE:TGT),” Palmer said. 

    He noted that, in addition, “reimbursement for dispensing drugs has been pressured by managed care and payers for years.” There have also been more alternatives than ever before, such as Amazon Pharmacy, GoodRx, or Mark Cuban’s Cost Plus.

    Read Next:

    • Privacy Risks Flagged: Major Pharmacy Chains Share Customer Data With Authorities Without Warrant.

    Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

    This image was created using artificial intelligence MidJourney.

    Get the next $CVS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CVS
    $MCK
    $TGT
    $WBA

    CompanyDatePrice TargetRatingAnalyst
    Target Corporation
    $TGT
    1/27/2026Underperform → Peer Perform
    Wolfe Research
    Target Corporation
    $TGT
    1/8/2026Hold
    Deutsche Bank
    Walmart Inc.
    $WMT
    1/8/2026$119.00Buy → Hold
    Deutsche Bank
    McKesson Corporation
    $MCK
    12/9/2025$960.00Overweight
    Barclays
    Walmart Inc.
    $WMT
    11/21/2025$118.00 → $130.00Outperform
    Telsey Advisory Group
    Walmart Inc.
    $WMT
    10/15/2025$120.00Buy
    BTIG Research
    Target Corporation
    $TGT
    10/15/2025Neutral
    BTIG Research
    CVS Health Corporation
    $CVS
    10/14/2025$91.00Buy
    Goldman
    More analyst ratings

    $CVS
    $MCK
    $TGT
    $WBA
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    September 12, 2023 - FDA Issues Warning Letters to Firms Marketing Unapproved Eye Products

    For Immediate Release: September 12, 2023 The U.S. Food and Drug Administration has issued warning letters to eight companies for manufacturing or marketing unapproved ophthalmic drug products in violation of federal law. These warning letters are part of the agency’s ongoing effort to protect Americans from potentially harmful ophthalmic products. Eye products addressed in the eight warning letters are illegal

    9/12/23 10:44:21 AM ET
    $WBA
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $CVS
    $MCK
    $TGT
    $WBA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP and Chief Legal Officer Lau Michele converted options into 4,748 shares and covered exercise/tax liability with 1,720 shares, increasing direct ownership by 93% to 6,275 units (SEC Form 4)

    4 - MCKESSON CORP (0000927653) (Issuer)

    2/11/26 3:25:35 PM ET
    $MCK
    Other Pharmaceuticals
    Health Care

    New insider Milum Dwayne M claimed ownership of 42,526 units of Common (SEC Form 3)

    3 - Walmart Inc. (0000104169) (Issuer)

    2/10/26 5:08:10 PM ET
    $WMT
    Department/Specialty Retail Stores
    Consumer Discretionary

    New insider Dallaire Seth claimed ownership of 487,728 units of Common (SEC Form 3)

    3 - Walmart Inc. (0000104169) (Issuer)

    2/10/26 5:06:41 PM ET
    $WMT
    Department/Specialty Retail Stores
    Consumer Discretionary

    $CVS
    $MCK
    $TGT
    $WBA
    SEC Filings

    View All

    Target Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - TARGET CORP (0000027419) (Filer)

    2/11/26 6:30:39 AM ET
    $TGT
    Department/Specialty Retail Stores
    Consumer Discretionary

    Target Corporation filed SEC Form 8-K: Leadership Update

    8-K - TARGET CORP (0000027419) (Filer)

    2/10/26 7:01:58 AM ET
    $TGT
    Department/Specialty Retail Stores
    Consumer Discretionary

    SEC Form 10-K filed by CVS Health Corporation

    10-K - CVS HEALTH Corp (0000064803) (Filer)

    2/10/26 6:36:59 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $CVS
    $MCK
    $TGT
    $WBA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Jodie Turner-Smith, Rachel Zoe, Ciara Miller, Ming Lee Simmons, Whitney Leavitt, Lana Condor, and More Glow at The Spring Beauty Studio at Target SoHo during NYFW

    NEW YORK, Feb. 11, 2026 /PRNewswire/ -- Target announced its largest Spring beauty assortment to date. To celebrate, Target hosted a dynamic event: The Target Spring Beauty Studio, kicking off New York Fashion Week at its concept store in New York City's SoHo. This event showcased what's new and next in beauty at Target. Who: Jodie Turner-Smith (Actress), Rachel Zoe (Designer), Ciara Miller (Model), Ming Lee Simmons (Model), Whitney Leavitt (Actress), Lana Condor (Actress), Kahlana Barfield Brown (Fashion and Beauty Expert), Xia Charles (Content Creator), Katie Fang (Content Creator), Ana Zortea (Influencer) What: Target kicked off New York Fashion Week with the Spring Beauty Studio event in

    2/11/26 3:57:00 PM ET
    $TGT
    Department/Specialty Retail Stores
    Consumer Discretionary

    Circana Appoints Highly Regarded Business Leaders to Board of Directors

    Chicago, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Circana LLC, a leading global provider of data, insights, and advisory services, today announced the appointment of three new members to its Board of Directors: Brian Cornell, Executive Chair of Target Corp.; Lauren Cooks Levitan, Co-Founder and Co-CEO of ROOT and Lead Independent Director at e.l.f. Beauty, Inc.; and Rohit Prasad, former Senior Vice President and Head Scientist of Artificial General Intelligence at Amazon.com, Inc. "These appointments strengthen the Board's ability to guide Circana's strategy and accelerate the value we deliver to our global clients," said Stuart Aitken, President and CEO of Circana. "We are focused on advancing

    2/11/26 8:00:00 AM ET
    $AMZN
    $TGT
    Catalog/Specialty Distribution
    Consumer Discretionary
    Department/Specialty Retail Stores

    Target Announces Executive Leadership Changes to Accelerate Growth, Confirms Q4 Financial Guidance

    MINNEAPOLIS, Feb. 10, 2026 /PRNewswire/ -- Target Corporation (NYSE: TGT) announces a series of executive leadership changes under new CEO Michael Fiddelke aimed at accelerating the company's growth plans. The appointments follow recent additions to the Board of Directors and directly support Fiddelke's focus on strengthening merchandising authority and elevating the guest experience. The company also confirms that it expects to report fourth quarter 2025 sales, full-year GAAP EPS and full-year Adjusted EPS in line with its prior guidance. "It's the start of a new chapter for Target and we're moving quickly to take action against our priorities that will drive growth within our business," sa

    2/10/26 7:00:00 AM ET
    $TGT
    Department/Specialty Retail Stores
    Consumer Discretionary

    $CVS
    $MCK
    $TGT
    $WBA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    $CVS
    $MCK
    $TGT
    $WBA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Target upgraded by Wolfe Research

    Wolfe Research upgraded Target from Underperform to Peer Perform

    1/27/26 8:35:35 AM ET
    $TGT
    Department/Specialty Retail Stores
    Consumer Discretionary

    Deutsche Bank initiated coverage on Target

    Deutsche Bank initiated coverage of Target with a rating of Hold

    1/8/26 10:59:33 AM ET
    $TGT
    Department/Specialty Retail Stores
    Consumer Discretionary

    Walmart downgraded by Deutsche Bank with a new price target

    Deutsche Bank downgraded Walmart from Buy to Hold and set a new price target of $119.00

    1/8/26 8:25:32 AM ET
    $WMT
    Department/Specialty Retail Stores
    Consumer Discretionary

    EVP and President, Aetna Nelson Steven H bought $1,289 worth of shares (24 units at $53.70) (SEC Form 4)

    4 - CVS HEALTH Corp (0000064803) (Issuer)

    1/27/26 5:20:15 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    EVP and Chief People Officer Capozzi Heidi B bought $4,589 worth of shares (80 units at $57.36) (SEC Form 4)

    4 - CVS HEALTH Corp (0000064803) (Issuer)

    10/14/25 7:08:15 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Director Sansone Guy P bought $100,009 worth of shares (1,570 units at $63.70), increasing direct ownership by 15% to 12,007 units (SEC Form 4)

    4 - CVS HEALTH Corp (0000064803) (Issuer)

    6/9/25 8:22:46 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $CVS
    $MCK
    $TGT
    $WBA
    Leadership Updates

    Live Leadership Updates

    View All

    Circana Appoints Highly Regarded Business Leaders to Board of Directors

    Chicago, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Circana LLC, a leading global provider of data, insights, and advisory services, today announced the appointment of three new members to its Board of Directors: Brian Cornell, Executive Chair of Target Corp.; Lauren Cooks Levitan, Co-Founder and Co-CEO of ROOT and Lead Independent Director at e.l.f. Beauty, Inc.; and Rohit Prasad, former Senior Vice President and Head Scientist of Artificial General Intelligence at Amazon.com, Inc. "These appointments strengthen the Board's ability to guide Circana's strategy and accelerate the value we deliver to our global clients," said Stuart Aitken, President and CEO of Circana. "We are focused on advancing

    2/11/26 8:00:00 AM ET
    $AMZN
    $TGT
    Catalog/Specialty Distribution
    Consumer Discretionary
    Department/Specialty Retail Stores

    Target Appoints Former Nike and HanesBrands Executives to Board of Directors

    John Hoke, former Chief Innovation Officer at NIKE, Inc., will join the Board on March 1 and serve on the Governance & Sustainability and the Compensation & Human Capital Management committeesSteve Bratspies, former CEO of HanesBrands, will join the Board on April 1 and serve on the Audit & Risk and the Infrastructure & Finance committeesThe appointments come as Target prepares for its next chapter of growth under incoming CEO Michael FiddelkeMINNEAPOLIS, Jan. 22, 2026 /PRNewswire/ -- Target Corporation (NYSE:TGT) announced today the election of two accomplished retail leaders to its Board of Directors: John Hoke, III, former chief innovation officer at NIKE, Inc., and Steve Bratspies, forme

    1/22/26 11:00:00 AM ET
    $TGT
    Department/Specialty Retail Stores
    Consumer Discretionary

    Walmart Inc. to Join the Nasdaq-100 Index® Beginning January 20th, 2026

    NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Nasdaq (NASDAQ:NDAQ) today announced that Walmart Inc. (NASDAQ:WMT), will become a component of the Nasdaq-100 Index® (NDX®), the Nasdaq-100 Equal Weighted™ Index (NDXE™), and the Nasdaq-100 Ex-Tech Sector™ Index (NDXX™) prior to market open on Tuesday, January 20, 2026 - the first trading day following the third Friday of the month. Walmart Inc. will replace AstraZeneca PLC (NASDAQ:AZN) in the Nasdaq-100 Index®, the Nasdaq-100 Equal Weighted Index, and the Nasdaq-100 Ex-Tech Sector Index. AstraZeneca PLC will also be removed from the Nasdaq-100 ESG™ Index (NDXESG™), Nasdaq-100 ex Top 30™​ (NDX70™), Nasdaq-100 ex Top 30​ UCITS™ (NDX70U™), Nasdaq

    1/9/26 8:00:00 PM ET
    $AZN
    $NDAQ
    $WMT
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Investment Bankers/Brokers/Service
    Finance

    $CVS
    $MCK
    $TGT
    $WBA
    Financials

    Live finance-specific insights

    View All

    Target Announces Executive Leadership Changes to Accelerate Growth, Confirms Q4 Financial Guidance

    MINNEAPOLIS, Feb. 10, 2026 /PRNewswire/ -- Target Corporation (NYSE: TGT) announces a series of executive leadership changes under new CEO Michael Fiddelke aimed at accelerating the company's growth plans. The appointments follow recent additions to the Board of Directors and directly support Fiddelke's focus on strengthening merchandising authority and elevating the guest experience. The company also confirms that it expects to report fourth quarter 2025 sales, full-year GAAP EPS and full-year Adjusted EPS in line with its prior guidance. "It's the start of a new chapter for Target and we're moving quickly to take action against our priorities that will drive growth within our business," sa

    2/10/26 7:00:00 AM ET
    $TGT
    Department/Specialty Retail Stores
    Consumer Discretionary

    CVS HEALTH CORPORATION REPORTS FOURTH QUARTER AND FULL-YEAR 2025 RESULTS

    Fourth Quarter Highlights Total revenues increased to $105.7 billion, up 8.2% compared to prior yearGAAP diluted EPS of $2.30 and Adjusted EPS of $1.09Full-Year Highlights Total revenues increased to a record high $402.1 billion, up 7.8% compared to prior yearGAAP diluted EPS of $1.39 and Adjusted EPS of $6.75Generated cash flow from operations of $10.6 billionOperational Highlights CVS Pharmacy® successfully completed the transition to cost-based reimbursement across its Commercial, Third-Party Discount, Medicare and Medicaid businesses.Aetna® continues to improve the experience for health care professionals and their patients, approving more than 95% of all eligible prior authorizations wi

    2/10/26 6:30:00 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    McKesson Corporation Reports Fiscal 2026 Third Quarter Results and Raises Full Year Adjusted EPS Guidance

    McKesson Corporation (NYSE:MCK) has released its fiscal 2026 third quarter financial results. Results can be accessed on McKesson's Investor Relations website at investor.mckesson.com/financials/quarterly-results. As previously announced, the company will host a live webcast of the earnings conference call for investors today, Wednesday, February 4 at 4:30 PM ET to review its financial results. The audio webcast of the conference call will be available live and archived on McKesson's Investor Relations website, along with the company's earnings press release, financial tables, and slide presentation. Additional information about upcoming events for the investor community can be found at i

    2/4/26 4:10:00 PM ET
    $MCK
    Other Pharmaceuticals
    Health Care

    $CVS
    $MCK
    $TGT
    $WBA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by CVS Health Corporation

    SC 13G - CVS HEALTH Corp (0000064803) (Subject)

    11/13/24 1:00:57 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Amendment: SEC Form SC 13G/A filed by Target Corporation

    SC 13G/A - TARGET CORP (0000027419) (Subject)

    11/13/24 12:52:42 PM ET
    $TGT
    Department/Specialty Retail Stores
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Walgreens Boots Alliance Inc.

    SC 13G/A - Walgreens Boots Alliance, Inc. (0001618921) (Subject)

    10/18/24 12:45:41 PM ET
    $WBA
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples